Search Results - Botty, R. El

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers

    Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers by Coussy, F, El Botty, R, Lavigne, M, Gu, C, Fuhrmann, L, Briaux, A, de Koning, L, Dahmani, A, Montaudon, E, Morisset, L, Huguet, L, Sourd, L, Painsec, P, Chateau-Joubert, S, Larcher, T, Vacher, S, Melaabi, S, Salomon, A Vincent, Marangoni, E, Bieche, I

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Clinical value of R-spondins in triple-negative and metaplastic breast cancers

    Clinical value of R-spondins in triple-negative and metaplastic breast cancers by Coussy, F, Lallemand, F, Vacher, S, Schnitzler, A, Chemlali, W, Caly, M, Nicolas, A, Richon, S, Meseure, D, El Botty, R, De-Plater, L, Fuhrmann, L, Dubois, T, Roman-Roman, S, Dangles-Marie, V, Marangoni, E, Bièche, I

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) appears as an efficient targeted therapy when used in an adjuvant setting in patient-derived xenografts of uveal melanoma

    The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) appears as an efficient targeted therapy when used in an adjuvant setting in patient-derived xenografts of uveal melanoma by Diallo, B, Massonnet, G, El-Botty, R, Raymondie, C, Howes, C, Wilson, J, Smith, A, Roman-Roman, S, Smith, P, Davies, E, Decaudin, D, Némati, F

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    280 (PB268): Response to precision-guided treatments in patient-derived models of metastatic breast cancer

    280 (PB268): Response to precision-guided treatments in patient-derived models of metastatic breast cancer by Montaudon, E., Planchon, J. Masliah, Dahmani, A., Huguet, L., Sourd, L., Morriset, L., Derrien, H., Botty, R. El, Nemati, F., Dutertre, G., Cabel, L., Bieche, I., Coussy, F., Marangoni, E.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    400 - The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) appears as an efficient targeted therapy when used in an adjuvant setting in patient-derived xenografts of uveal melanoma

    400 - The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) appears as an efficient targeted therapy when used in an adjuvant setting in patient-derived xenografts of uveal melan... by Diallo, B., Massonnet, G., El-Botty, R., Raymondie, C., Howes, C., Wilson, J., Smith, A., Roman-Roman, S., Smith, P., Davies, E., Decaudin, D., Némati, F.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract P5-09-07: Identification of resistance-specific gene expression signatures in a breast cancer patient-derived xenograft with acquired resistance to different endocrine therapies

    Abstract P5-09-07: Identification of resistance-specific gene expression signatures in a breast cancer patient-derived xenograft with acquired resistance to different endocrine the... by Cottu, PH, Bièche, I, de la Grange, P, Gentien, D, Assayag, F, Thuleau, A, El-Botty, R, Chateau-Joubert, S, Huerre, M, Hatem, R, Richon, S, Slimane, K, Marangoni, E

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Metabolic Response to Everolimus in Patient-Derived Triple-Negative Breast Cancer Xenografts

    Metabolic Response to Everolimus in Patient-Derived Triple-Negative Breast Cancer Xenografts by Euceda, Leslie R, Hill, Deborah K, Stokke, Endre, Hatem, Rana, El Botty, Rania, Bièche, Ivan, Marangoni, Elisabetta, Bathen, Tone F, Moestue, Siver A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: